Source BioScience reports record-breaking financial results for 2015

Source BioScience has published its preliminary results for the 2015 business year, during which it delivered a revenue total of 26.3 million pounds.

This was up on the 25.2 million pound total from 2014 and marks a new record for the company, which also saw improvements in its earnings, profits and its cash flow performance during the year.

Over the course of 2015, the firm was able to complete its acquisitions of Select Pharma Laboratories and BritainsDNA, with more than one million DNA sequencing reads delivered in the year.

Other key highlights included the launch of its enhanced Just Between Us online sexual health service and the award of a first contract with the European Centre for Disease Control for next-generation DNA sequencing.

The company will be seeking to build on this performance by further expanding its services and capabilities in the year to come.

Laurie Turnbull, chairman of Source BioScience, said: "Source BioScience now offers a broad portfolio of laboratory services and products to customers, extending its reach into new geographical markets, providing not only a more diversified and balanced business but also outstanding opportunities for increased sales and expansion."